Episode 19: NIVOPOSTOP - nivolumab post op - a GORTEC triump with Yungan Tao

from Deep Margin · host Dr Ben O'Leary and Dr Will Ince

Yungan Tao President-Elect GORTEC, and Radiation Oncologist in Head and Neck cancer at Institut Gustave-Roussy talks us through the NICOPOSTOP trial. Will risks diplomatic incidents and out European tour continues.

Episode metadata supplied by the publisher feed · Published May 11, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Episode 19: NIVOPOSTOP - nivolumab post op - a GORTEC triump with Yungan Tao

0:00 38:14

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Deep Margin?

This episode is 38 minutes long.

When was this Deep Margin episode published?

This episode was published on May 11, 2026.

Can I download this Deep Margin episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!